The challenge with these fatty acids was their physical properties. As free fatty acids, they are waxy solids at room temperature. They do not dissolve in water. When injected as part of the natural oil, they pooled in tissue because there was no mechanism to disperse and absorb them into the bloodstream. The body processes fatty acids through established metabolic pathways, but those pathways require the fatty acids to be presented in a form that cell membranes can interact with. Raw plant oil injected directly into subcutaneous tissue doesn’t follow those pathways efficiently.

 

Ball’s approach was to convert the fatty acids into their ethyl ester forms. An ester is formed by a reaction between an acid and an alcohol — in this case, between the fatty acids and ethanol. The resulting ethyl esters have different physical properties from the parent acids: they are less viscous, more soluble in aqueous solution, and more amenable to forming stable injectable preparations. Critically, the body’s lipase enzymes can cleave the ester bond and release the active fatty acid, meaning the therapeutic compound becomes bioavailable after injection in a way that the raw oil never was.

 

The specific technical achievement was producing a stable, sterile, water-compatible injectable preparation from these ethyl esters. This required not just understanding the chemistry but working out the practical details of preparation: the extraction conditions, the esterification process, the purification steps, the final formulation. It required the kind of detailed, iterative laboratory work that gets encoded in a protocol — a method that someone else could follow and reproduce.

ADVERTISEMENT
Advertisement
Share.